Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease

Judith Wellens, Matthew Edmans, Uri Obolski, Colleen G.C. McGregor, Peter Simmonds, Marc Turner, Lisa Jarvis, Donal Skelly, Susanna Dunachie, Eleanor Barnes, David W. Eyre, Jean Frederic Colombel, Serre Yu Wong, Paul Klenerman, James O. Lindsay, Jack Satsangi, Craig P. Thompson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1919-1922
Number of pages4
Issue number9
StatePublished - Sep 2022


FundersFunder number
Leona M. and Harry B. Helmsley Charitable TrustCOV19-RECPLAS
KU Leuven

    Cite this